SOPHARMA AD - Supplement No 1 to the exemption document dated 7 November 2025

Spis treści:
1. REPORT
2. INFORMATION ABOUT THE ENTITY
3. SIGNATURE OF PERSONS REPRESENTING THE COMPANY

Spis załączników:

1. 08012026 - supplement to Exemption Doc.rarSupplement No 1 to the exemption document dated 7 November 2025
   

POLISH FINANCIAL SUPERVISION AUTHORITY

UNI - EN REPORT No 4 / 2026

Date of issue: 2026-01-08

Short name of the issuer

SOPHARMA AD

Subject

Supplement No 1 to the exemption document dated 7 November 2025

Official market - legal basis

Art. 56. 1. 2 of Act on Public Offering

Unofficial market - legal basis

Contents of the report:

Sofia, Bulgaria, January 8, 2026 – In reference to current report No. 220/2025 dated 7 November 2025, “Sopharma” AD (SFA: Bulgarian Stock Exchange AD, SPH: Warsaw Stock Exchange) has published a supplement to the exemption document dated 7 November 2025 (the “Exemption Document”)(the “Supplement”). The Supplement has been prepared in order to introduce a correction to the content of the Exemption Document. The Supplement, along with the Exemption Document, are available on the website (https://www.sopharmagroup.com/en/home/investors/prospectuses) of “Sopharma” AD.

Annexes

File Description

08012026 - supplement to Exemption Doc.rar08012026 - supplement to Exemption Doc.rar Supplement No 1 to the exemption document dated 7 November 2025

SOPHARMA AD

(fullname of the issuer)

SOPHARMA AD Farmaceutyczny (far)

(short name of the issuer) (sector according to clasification of the WSE in Warsow)

1220 Sofia

(post code) (city)

IlienskoShosse 16

(street) (number)

[phone] [phone]

(phone number) (fax)

(e-mail) (web site)

nd

(NIP) (REGON)

SIGNATURE OF PERSONS REPRESENTING THE COMPANY

Date Name Position / Function Signature

2026-01-08 Ognian Ivanov Donev Executive Director